Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 23/06/2024 BST			5-day change	1st Jan Change
4.923 ^DKK	-3.25%		-3.03%	+5.12%

06-17	CS Medica Completes Cannabidiol Medical Device Registration Process in Israel	MT
06-12	CS Medica to Boost Denmark Operations With OneMed Partnership	MT

CS Medica A/S agreed to Spin-Off Cannordic A/S.

June 09, 2024

CS Medica A/S (NGM:CSMED) agreed to spin-off Cannordic A/S on June 10, 2024. The board members of CS MEDICA announced the approval to spin off 20% of its wholly-owned subsidiary CANNORDIC A/S. The extraordinary general assembly to approve this transaction is scheduled for June 2024. The transaction and stock market listing are planned to be completed by the end of 2024.

Latest news about CS MEDICA A/S

CS Medica Completes Cannabidiol Medical Device Registration Process in Israel	06-17	MT
CS Medica to Boost Denmark Operations With OneMed Partnership	06-12	MT
CS MEDICA Announces Strategic Partnership with OneMed	06-12	CI
CS Medica, GP Europe Sign Letter of Intent for Potential Hemp Products Partnership	06-11	MT
CS Medica A/S Announces Strategic Expansion Through Innovation and Collaboration	06-11	CI
CS Medica Advances Spin-off, Listing Plans in Germany for Cannordic Unit	06-10	MT
CS Medica A/S agreed to Spin-Off Cannordic A/S.	06-09	CI
Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024	05-23
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-17	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	04-30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	04-22	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	04-12
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04-04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	02-21
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	02-20	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	02-02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	01-26	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	12-27	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	12-05
CS Medica A/S Announces Financial Year Change	11-22	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	11-22	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	11-22	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	31/10/23	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	12/10/23	CI
Danske Bank Extends DKK 1.2 Million Credit Line to CS MEDICA	10/10/23	CI

Chart CS MEDICA A/S

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar